U-Blot® Research Grade SonepcizumabCat. No. WA3556Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade SonepcizumabCat. No. WA3556U-Blot® Research Grade SonelokimabCat. No. WA3555Request quote
Size: 50ug/100ug
U-Blot® Research Grade SonefpeglutideCat. No. WA3554Request quote
Size: 50ug/100ug
U-Blot® Research Grade SonavibartCat. No. WA3553Request quote
Size: 50ug/100ug
U-Blot® Research Grade SolrikitugCat. No. WA3552Request quote
Size: 50ug/100ug
U-Blot® Research Grade solnerstotugCat. No. WA3551Request quote
Size: 50ug/100ug
U-Blot® Research Grade SolitomabCat. No. WA3550Request quote
Size: 50ug/100ug
U-Blot® Research Grade solaprubartCat. No. WA3549Request quote
Size: 50ug/100ug
U-Blot® Research Grade SolanezumabCat. No. WA3548Request quote
Size: 50ug/100ug
U-Blot® Research Grade solabafusp alfaCat. No. WA3547Request quote
Size: 50ug/100ug
U-Blot® Research Grade SofituzumabCat. No. WA3546Request quote
Size: 50ug/100ug
U-Blot® Research Grade SocazolimabCat. No. WA3545Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598